Favorable
Showing 1 - 25 of 4,766
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Resected Pancreatic and Ampullary Adenocarcinoma at Favorable
Enrolling by invitation
- Resectable Pancreatic Adenocarcinoma
-
Milan, ItalyNational Cancer Institute of Milan
Mar 3, 2023
Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),
Recruiting
- Oropharynx Cancer
- Radiation therapy (5 days for 7 weeks)
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 5, 2023
COVID, Corona Virus Infection, Adverse Event Trial in New York (EPIC risk score display)
Completed
- COVID
- +2 more
- EPIC risk score display
-
New York, New YorkNYU Langone Health
Dec 22, 2022
Oligohydramnios, Delivered Trial in Khamis Mushait (observation of delivery and neonatal outcomes)
Completed
- Oligohydramnios, Delivered
- observation of delivery and neonatal outcomes
-
Khamis Mushait, Saudi ArabiaArmed Forces Hospitals Southern Region
Sep 28, 2022
Sublingual Microcirculation in Compensated T1D Using SDF Method
Recruiting
- Type1diabetes
-
Ústí Nad Labem, CzechiaMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Jul 14, 2023
Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)
Recruiting
- Breast Cancer
- IMRT/VMAT-Based Accelerated Partial Breast Irradiation
-
Worthington, Minnesota
- +2 more
Nov 11, 2022
PROSTATE CANCER Trial in Petah Tikva (Two-fraction stereotactic radiotherapy, Five-fraction stereotactic radiotherapy)
Recruiting
- PROSTATE CANCER
- Two-fraction stereotactic radiotherapy
- Five-fraction stereotactic radiotherapy
-
Petah Tikva, IsraelDavidoff Cancer Center, Rabin Medical Center
Sep 7, 2023
Cardiomyopathies, Heart Rate, Conditioning Trial in Iowa City (novel atrial pacing approach, sham pacing approach)
Enrolling by invitation
- Cardiomyopathies
- +2 more
- novel atrial pacing approach
- sham pacing approach
-
Iowa City, IowaUniversity of Iowa
Nov 19, 2022
Prostate Cancer, Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen Trial in San
Recruiting
- Prostate Cancer
- Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
- TRANBERG®|Thermal Therapy System
-
San Diego, CaliforniaGenesis Research LLC.
Apr 12, 2023
Prostate Cancer Trial in Toronto (SABR + HDR)
Recruiting
- Prostate Cancer
- SABR + HDR
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jun 12, 2022
Breast Cancer Radiation Trial in United States (Prosigna)
Active, not recruiting
- Breast Cancer Radiation
- Prosigna
-
Baltimore, Maryland
- +5 more
Jul 7, 2022
European Prospective Investigation Into Childhood Cancer
Not yet recruiting
- Establish Biobanking Initiative Among Southern European Children and Adolescents With Acute Lymphoblastic Leukemia and Favorable Biology Brain Tumors
- Observational
- (no location specified)
May 11, 2022
Gut Microbiome and Dietary Determinants and Vaccine Response
Recruiting
- Influenza
- Biospecimen Collection
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jun 28, 2022
Epilepsy Trial in New York (UPLIFT (Using Practice and Learning to Increase Favorable Thoughts), BOOST (Bringing Out Our
Recruiting
- Epilepsy
- UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)
- BOOST (Bringing Out Our Strength Together)
-
New York, New YorkNYU Langone Health
Aug 8, 2022
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
Prostate Cancer Trial in Chicago (Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the
Not yet recruiting
- Prostate Cancer
- Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate
-
Chicago, IllinoisNorthwestern University
Jun 17, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT, induction chemo, cisplatin concurrent chemo)
Recruiting
- Nasopharyngeal Carcinoma
- IMRT
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Universitty Cancer Center
May 5, 2022
Hemophilia A, Prophylaxis of Bleeding Trial (Damoctocog alfa-pegol (Jivi, BAY94-9027))
Not yet recruiting
- Hemophilia A
- Prophylaxis of Bleeding
- Damoctocog alfa-pegol (Jivi, BAY94-9027)
- (no location specified)
Jul 26, 2022
Prostate Cancer Trial in Ann Arbor, Detroit, Holland (Decipher, Prolaris, Oncotype Dx Genomic Prostate Score (GPS))
Recruiting
- Prostate Cancer
- Decipher
- +3 more
-
Ann Arbor, Michigan
- +3 more
Oct 26, 2021
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER Trial in United States (NAB-PACLITAXEL, PACLITAXEL)
Completed
- STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
-
Rochester, New York
- +4 more
Oct 5, 2021
Nasopharyngeal Carcinoma Trial in Guangzhou (RT plus Nimotuzumab, RT plus Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
- RT plus Nimotuzumab
- RT plus Cisplatin
-
Guangzhou, Guangdong, ChinaSun Yat-sen Universitty Cancer Center
Nov 3, 2021
Prostate Cancer Trial in United States (Prolaris Testing)
Terminated
- Prostate Cancer
- Prolaris Testing
-
Homewood, Alabama
- +33 more
Jun 17, 2022
Sleep Apnea, Sleep Apnea, Obstructive, Sleep Disordered Breathing Trial in Calgary (MATRx plus)
Completed
- Sleep Apnea
- +2 more
- MATRx plus
-
Calgary, Alberta, CanadaZephyr Sleep Technologies
Mar 3, 2021
Functional Recovery of Acute Ischemic Stroke Treated by
Not yet recruiting
- Acute Ischemic Stroke
- Quality of life Questionnaire
- (no location specified)
Jun 1, 2021